-
CMS takes action to stabilize ACA insurance market
It has often been said that when it comes to health insurance, what’s good for the insurance company may not be good for the physician or patients. That …
-
Advocacy Council participates in AMA workshop on alternative payment models
On March 20, the Advocacy Council participated in the AMA-sponsored Workshop on Alternative Payment Models (APM).The Advocacy Council’s APM sub-committee…
-
The “skinny” on narrow networks…
The Advocacy Council continues to hear from practicing allergists about limited (also called narrow or “skinny”) managed care networks. These are p…
-
Coalition to reform prior authorization requirements
The Advocacy Council recognizes the huge burden prior authorization’s put on allergy practices; one article states as much as 20 hours per week is attrib…
-
ACA and MACRA – they are not one and the same!
With the recent changes in Congress and the executive branch, it’s a challenge to keep track of the changes to health care reform. If you are confused ab…
-
Allergy & immunology and ICD-11
The International Classification of Diseases (ICD) by the World Health Organization (WHO) has been in use since 1900. Since it is only slightly more than a yea…
-
Why MACRA is probably a good thing for allergists
By now you’ve probably heard more than you care to about the Medicare Access and CHIP Reauthorization Act (MACRA), which became effective on Jan. 1. But …
-
MACRA recommendations that support the practicing allergist
As 2017 approaches, it’s time for you to begin preparing for the Medicare Access and CHIP Reauthorization Act (MACRA). While the final rule was already i…
-
CMS finds frequent errors in Medicare Advantage plans’ provider directories
你参与一个或更多的医疗保险如何ge (MA) plans? If so, we suggest you check your plan’s provider directory to make sure your listi…
-
Medical research and drug approval legislation making its way through Congress
Bipartisan legislation that seeks to expand our nation’s ability to undertake more research into the causes and cures for disease and, where possible, br…